Form 4 Tracker
Travere Therapeutics, Inc.
TVTX

50 insider filings · Latest: Jun 22, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 15, 2026Apr 16 1:48 AMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Sale
64,000$41.09$2.6M432,886(D)

View →

Apr 15, 2026Apr 16 1:47 AMElizabeth E ReedChief Legal Officer and GC
Sale
6,785$41.83$283.8K105,211(D)

View →

Apr 14, 2026Apr 16 1:47 AMElizabeth E ReedChief Legal Officer and GC
Sale
44,715$41.21$1.8M111,996(D)

View →

Apr 15, 2026Apr 16 1:46 AMChristopher R. ClineCHIEF FINANCIAL OFFICER
Sale
1,014$42.61$43.2K116,899(D)

View →

Apr 14, 2026Apr 16 1:46 AMChristopher R. ClineCHIEF FINANCIAL OFFICER
Sale
7,248$41.93$303.9K117,913(D)

View →

Apr 13, 2026Apr 16 1:46 AMChristopher R. ClineCHIEF FINANCIAL OFFICER
Sale
65$28.85$1.9K125,161(D)

View →

Apr 15, 2026Apr 16 1:46 AMJula InrigCHIEF MEDICAL OFFICER
Sale
1,018$42.61$43.4K111,473(D)

View →

Apr 14, 2026Apr 16 1:46 AMJula InrigCHIEF MEDICAL OFFICER
Sale
7,215$41.93$302.5K112,491(D)

View →

Apr 15, 2026Apr 15 8:16 PMDube Eric M
Proposed Sale
64,000$41.09$2.6M

View →

Apr 15, 2026Apr 15 8:15 PMELIZABETH REED
Proposed Sale
6,785$41.83$283.8K

View →

Apr 15, 2026Apr 15 8:14 PMCHRISTOPHER CLINE
Proposed Sale
1,014$42.61$43.2K

View →

Apr 15, 2026Apr 15 8:13 PMJULA INRIG
Proposed Sale
1,018$42.61$43.4K

View →

Apr 14, 2026Apr 15 1:17 AMElizabeth E. Reed
Proposed Sale
7,215$41.93$302.5K

View →

Apr 14, 2026Apr 15 12:53 AMJula Inrig
Proposed Sale
7,215$41.93$302.5K

View →

Apr 14, 2026Apr 15 12:47 AMPeter Heerma
Proposed Sale
7,215$41.93$302.5K

View →

Apr 14, 2026Apr 15 12:40 AMChristopher Cline
Proposed Sale
7,239$41.93$303.5K

View →

Apr 14, 2026Apr 14 8:27 PMGARY A LYONS
Proposed Sale
8,000$30.70$245.6K

View →

Apr 14, 2026Apr 14 8:20 PMCHRISTOPHER CLINE
Proposed Sale
9$41.07$370

View →

Apr 14, 2026Apr 14 8:19 PMELIZABETH REED
Proposed Sale
37,500$41.07$1.5M

View →

Apr 14, 2026Apr 14 8:09 PMROY BAYNES
Proposed Sale
32,750$41.29$1.4M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 12, 2026Jun 16 8:46 PMTimothy CoughlinDirector
Option Exercise
10,000$26.520(D)

View →

Jun 12, 2026Jun 16 8:42 PMRoy D. BaynesDirector
Option Exercise
4,500$21.380(D)

View →

May 19, 2026May 21 9:00 PMBrinkley Ruth WilliamsDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMRon SquarerDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMSandra PooleDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMJohn A OrwinDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMMeckler Jeffrey ADirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMLYONS GARY ADirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMTimothy CoughlinDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMSuzanne Louise BruhnDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 19, 2026May 21 9:00 PMRoy D. BaynesDirector
Grant/Award
12,000$42.2612,000(D)

View →

May 5, 2026May 7 12:00 AMRoy D. BaynesDirector
Option Exercise
4,500$18.270(D)

View →

May 4, 2026May 7 12:00 AMMeckler Jeffrey ADirector
Option Exercise
8,000$16.330(D)

View →

May 4, 2026May 7 12:00 AMWilliam E. RoteChief Research Officer
Option Exercise
4,2504,250(D)

View →

May 4, 2026May 7 12:00 AMWilliam E. RoteChief Research Officer
Grant/Award
8,5008,500(D)

View →

May 4, 2026May 7 12:00 AMElizabeth E ReedChief Legal Officer and GC
Option Exercise
24,250$17.964,250(D)

View →

May 4, 2026May 7 12:00 AMElizabeth E ReedChief Legal Officer and GC
Grant/Award
8,5008,500(D)

View →

May 4, 2026May 7 12:00 AMJula InrigCHIEF MEDICAL OFFICER
Option Exercise
24,250$22.404,250(D)

View →

May 4, 2026May 7 12:00 AMJula InrigCHIEF MEDICAL OFFICER
Grant/Award
8,5008,500(D)

View →

May 4, 2026May 7 12:00 AMPeter HeermaCHIEF COMMERCIAL OFFICER
Option Exercise
4,2504,250(D)

View →

Page 1 of 3

Next →